2021-06-09
The FDA granted an accelerated approval for aducanumab on June 7, 2021. The decision to approve a new treatment for Alzheimer’s disease in the USA creates opportunities for Swedish life science companies. Sweden Bio interviewed our CEO Kristina Torfgård about…
Read more
2021-06-08
The US Food and Drug Administration (FDA) communicated yesterday its decision to approve the investigational drug, aducanumab, for the… Read more
2021-06-07
In the US, June is Alzheimer's & Brain Awareness month. "The more people know about Alzheimer's, the more action… Read more
2021-06-02
2021-05-17
At Aktiespararna's Aktiedagen on Monday, our CEO, Kristina Torfgård provided an update on Alzinova and progress on the first… Read more
2021-05-05
On May 5 our CEO, Kristina Torfgård, attended the Captario Webinar together with AstraZeneca: From Small to Large in… Read more
2021-04-29
2021-04-16
Researchers are confident that it will soon be possible to do blood tests to see if there are signs… Read more
2021-04-09
Listen to the latest episode of Data, Pharma & Fika with our collaboration partner Captario, where Ingela Nylander our… Read more
2021-03-19
Our CEO, Kristina Torfgård, recently participated in a webcast discussion on Alzheimer's disease together with the CEOs of two… Read more
2021-03-03
Alzinova has recently initiated a collaboration with Captario to further optimize the company's development strategies. Read more
2021-03-01
Alzinova's CEO Kristina Torfgård was interviewed on February 26, 2021 by Redeye’s Life Science analyst Anders Hedlund. Read more
2021-02-25
"2020 was an important year and, our goal-oriented work has ensured that we are well prepared for the start… Read more
2021-02-10
Alzinova is collaborating with prominent researchers at Sahlgrenska University Hospital in Gothenburg, Sweden, to track markers of neurodegenerative change… Read more
2021-01-18
In a Research Note posted last week, equity research and investment banking company, Redeye, commented on “another external validation”… Read more
2020-09-14
World Alzheimer's Day takes place on 21 September and is part of World Alzheimer's Month, raising awareness for this disease… Read more
2020-06-16
Alzinova, a Swedish biopharmaceutical company developing disease-modifying treatments against Alzheimer’s Disease, has moved into AstraZeneca’s BioVentureHub in Gothenburg. Read more
